ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: PO0675

AKI due to COVID-19 in the Intensive Care Unit: Analysis of a Brazilian Center

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Neves, Precil D., Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Sato, Victor, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Mohrbacher, Sara, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Ferreira, Bernadete, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Pereira, Leonardo Victor, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Oliveira, Erico Souza de, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Bales, Alessandra Martins, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Nardotto, Luciana Loureiro, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Ferreira, Jéssica, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Machado, David, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Bassi, Estevao, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Silva-Junior, Amilton, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Chocair, Pedro, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
  • Cuvello neto, Americo Lourenço, Hospital Alemão Oswaldo Cruz, Sao Paulo, São Paulo, Brazil
Background

The kidney may be affected by coronavirus (COVID) in the setting of acute kidney injury (AKI) or glomerular diseases. Data about AKI in Intensive Care Unit (ICU) patients of Latin-America are scarce. The aim of this study is evaluate the risk of AKI, dialysis (HD) and death in ICU patients diagnosed with COVID pneumonia in a brazilian center.

Methods

Analysis from medical records of ICU patients with diagnosis of COVID pneumonia in a brazilian single-center. AKI was defined according to KDIGO criteria.

Results

During the period of February 2nd to May 4th, 95 ICU patients diagnosed with COVID were analyzed. There was predominance of male (64.2%), median age of 64.9 years, previous diagnosis of hypertension, diabetes and obesity in 51.6%, 27.4 and 30.5% respectively. AKI was diagnosed in 54 (56.8%) patients and 32 (59.2%) of them required HD. Mortality rate was 17.9%. Patients with AKI, compared to no-AKI were statisticaly significant more frequently hypertensive and diabetic, worse SAPS3 and SOFA scores and need for organ support therapies. Laboratory tests depicted more anemia, lymphopenia, and higher levels of inflamatory markers as well as longer lenght of stay in ICU, hospital and death. Similar findings were seen in those ones who required HD compared to those with conservador treatment. Comparing patients who undergone death to survivors, they were older, more frequently diabetic, worse SAPS3 and SOFA scores and need for organ support therapies, AKI and dialysis. Multinomial logistic regression predicted that hypertension (p=0.01), mechanical ventilation (p=0.01) and use of hydroxychloroquine (p=0.009) were independent risks factors for AKI; hypertension (p=0.002), mechanical ventilation (p=0.03), use of vasopressor (p=0.04), and use of hydroxychloroquine (p=0.009) for HD patients; and age >65 years (p=0.03) and AKI (p=0.04) for death.

Conclusion

In our study, AKI was a common complication of ICU COVID patients, it was associated to hypertension, organ support therapies and use of hydroxichloroquine. As well as age >65 years, AKI was an independent risk fator to death.